Search Results - microbiology+and+infectious+disease+treatments

42 Results

Sort By:

Application Modified Vaccinia virus Ankara (MVA)- and deoxyribonucleic acid (DNA)-based vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Key Benefits Safety profile is known. Demonstrated antiviral activity against related Coronaviruses. Single dose of vaccination was shown to be effective against related Coronaviruses...

Published: 2/13/2025 | Inventor(s): Rama Rao Amara, Sailaja Gangadhara

Keywords(s): Biologics, COVID19, DNA and RNA Vaccines, Immunology and Inflammation Treatments, Microbiology and Infectious Disease Treatments

Category(s): TechPub Algolia > Vaccines

Combination Antibiotic Therapy to Exploit Multiple Heteroresistance

Application Treatment with combinations of FDA-approved antibodies targeting small drug-resistant cell populations for infectious disease. Key Benefits Specific combinations of existing drugs that target small subpopulations of bacterial cells resistant to many standard of care treatment regimens. Potential to overcome the drug resistance crisis...

Published: 2/28/2025 | Inventor(s): David Weiss, David Hufnagel, Victor Band

Keywords(s): Microbiology and Infectious Disease Treatments

Category(s): TechPub Algolia > Diagnostics, TechPub Algolia > Therapeutics

Vaccines and Antibody Therapeutics for HPV-related Cancers

Application Treatment and prevention of HPV-induced malignancies. Key Benefits Identification of a protein expressed in a large number of HPV-induced cancers. Antibodies have been generated that bind to the protein and potentially elicit an immune response to the cancer cells. The antibodies can be used to develop new treatments and vaccines...

Published: 2/13/2025 | Inventor(s): Rafi Ahmed, Andreas Wieland

Keywords(s): Biologics, Microbiology and Infectious Disease Treatments, Oncology Treatments, Preventive Vaccines

Category(s): TechPub Algolia > Therapeutics

EF-Tu Targeting Antibody for Infection Treatment

Application Therapeutic monoclonal antibodies directed to Elongation Factor-Tu (EF-Tu) for the treatment of infections. Key Benefits An antibody that targets the protein EF-Tu, which is present on many types of bacteria involved in life-threatening infections. A research-grade antibody has been developed with animal data showing the ability to...

Published: 2/13/2025 | Inventor(s): Joanna Goldberg, Dina Moustafa

Keywords(s): Antibodies, Microbiology and Infectious Disease Treatments, Therapeutic Vaccines

Category(s): TechPub Algolia > Vaccines, TechPub Algolia > Therapeutics

Generation of Vaccines Preventing the Common Cold

Application A new class of vaccines targeting the viruses causing the common cold, rhinoviruses (RV). Key Benefits Capsid-chimeric strains for developing new RV vaccines. Preclinical data with a prototype show the ability to induce a robust capsid-specific immune response. Straightforward and inexpensive vaccine manufacturing process utilizing...

Published: 2/13/2025 | Inventor(s): Sujin Lee

Keywords(s): Chemistry, Microbiology and Infectious Disease Treatments, Recombinant Vaccines

Category(s): TechPub Algolia > Vaccines

Reagents and Hardware for RNA Storage at Ambient Temperatures

Application Simple and economical method for isolating and storing RNA from biological samples at room temperatures. Key Benefits Alternative, low-cost extraction method suitable for extracting RNA from biological samples for molecular analysis and disease diagnosis. Eliminates the need for expensive proprietary materials, hazardous chemicals,...

Published: 2/13/2025 | Inventor(s): Jesse Waggoner, David Myers, Sarah Hernandez, Dhruv Miglani

Keywords(s): Chemistry, Microbiology and Infectious Disease Treatments

Category(s): TechPub Algolia > Micro and Nanotechnology

RSV Vaccine for Infants and Children

Application Vaccine for Respiratory Syncytial Virus (RSV) in infants and children. Key Benefits A novel vaccine targeting both the F and G proteins of the respiratory syncytial virus (RSV), including its variants. Preliminary data in in mice show the vaccine induced the production of antibodies associated with preventing disease. Potential to...

Published: 2/13/2025 | Inventor(s): Larry Anderson, Binh Ha, Heying Sun

Keywords(s): Microbiology and Infectious Disease Treatments, Pediatrics, Respiratory Treatments

Category(s): TechPub Algolia > Vaccines

Therapeutic for Potential Elimination of Chronic Hepatitis B

Application A therapeutic technique to eliminate infection of patients suffering from chronic Hepatitis B Virus infection. Key Benefits May provide a cure for chronic HBV infection rather than just simple management. High efficiency of infection targeting may produce minimal side effects. May be used in combination with other HBV inhibitors. Market...

Published: 2/28/2025 | Inventor(s): Raymond Schinazi, Leda Bassit, Ting Nie

Keywords(s): Gene Therapy and Editing, Microbiology and Infectious Disease Treatments

Category(s): TechPub Algolia > Therapeutics

SARS-CoV-2 Neutralizing Human Monoclonal Antibodies

Application Monoclonal antibodies to SARS-CoV2 for use in COVID-19 diagnostics and therapeutics. Key Benefits Demonstrably neutralizing, important for therapeutic mAbs. Most bind both RBG and stalk portion of spike protein, useful in case SARS-CoV2 strains develop variation in RBD. Market Summary Coronavirus (COVID-19) is an infectious...

Published: 2/13/2025 | Inventor(s): Jens Wrammert, Carl Davis, Mehul Suthar, Robert Kauffman

Keywords(s): Antibodies, COVID19, Microbiology and Infectious Disease Treatments

Category(s): TechPub Algolia > Diagnostics, TechPub Algolia > Therapeutics

Isolation of Therapeutic cells and Framework for Adoptive Cell Therapies

Application Isolation of therapeutic cells and framework for adoptive cell therapies based around stem-like chronic memory CD8 T cells that may be paired with PD-1 blockade. Key Benefits Persistent cell survival and therapeutic efficacy following rechallenge with chronic viral infection and cancer. Strong co-treatment potential with PD-1...

Published: 2/13/2025 | Inventor(s): Rafi Ahmed, Daniel Chang

Keywords(s): Cell Therapy, Microbiology and Infectious Disease Treatments, Oncology Treatments

Category(s): TechPub Algolia > Therapeutics

1 2 3 4 5